AMCP Develops Concepts for Effective Prior Authorization
AMCP has developed nine concepts around the effective use of prior authorization that managed care organizations can follow to ensure that PA processes are timely, transparent, collaborative and supportive of patient-centered care.

Managed Care and Specialty Pharmacy Professionals Identify Barriers and Solutions to Increasing Biosimilar Adoption
A new survey conducted by AMCP and PRIME Education assesses various strategies that managed care and specialty pharmacy professionals could adopt to overcome barriers and boost biosimilar utilization.

AMCP Brand Revitalization Reflects Forward-Thinking Approach
AMCP: Optimizing Medicine. Improving Lives. That’s the message of AMCP’s revitalized brand and logo, which were unveiled at the AMCP Annual Meeting in late March 2019.

AMCP Releases Survey on Part D MTM’s Standardized Format
Nearly 63 percent of Medicare beneficiaries say they would recommend MTM services provided under the Part D prescription drug program to friends and relatives.

Statement on HHS Proposal to Eliminate Rebates Under Medicare Part D
AMCP CEO Susan A. Cantrell, RPh, CAE, issued a statement on the HHS proposal to eliminate negotiated rebates for pharmaceuticals under Medicare Part D and managed Medicaid programs.

AMCP Urges FDA to Issue Final Guidance on Biosimilar Interchangeability Standards
AMCP urges FDA to issue final guidance on interchangeability standards and develop educational materials on biosimilars.

AMCP Explains PIE Act (H.R. 2026) in Info-Graphic
AMCP has prepared a one-page, easy-to-understand info-graphic on the PIE Act (H.R. 2026)

Emerging Trends Update: The Rx Affordability Crisis
The AMCP Foundation is pleased to present the second in a series of articles bridging the predictions from the Emerging Trends body of knowledge to current health care realities.

Drug Pricing Summary
AMCP has compiled a comprehensive summary of recent actions aimed at drug pricing by the White House, Congress and the states.